BC Week In Review | Oct 27, 2008
Clinical News

Acanya gel regulatory update

FDA approved an NDA from Dow for topical Acanya gel to treat acne vulgaris in patients 12 years and older. Acanya is a combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% in a gel....
Items per page:
1 - 1 of 1